240 related articles for article (PubMed ID: 25541382)
1. Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis.
Le Teuff G; Abrahamowicz M; Wynant W; Binquet C; Moreau T; Quantin C
J Clin Epidemiol; 2015 Mar; 68(3):307-16. PubMed ID: 25541382
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis.
Binquet C; Quantin C; Le Teuff G; Pagliano JF; Abrahamowicz M; Moreau T
Neuroepidemiology; 2006; 27(1):45-54. PubMed ID: 16825794
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.
Rotstein DL; Healy BC; Malik MT; Chitnis T; Weiner HL
JAMA Neurol; 2015 Feb; 72(2):152-8. PubMed ID: 25531931
[TBL] [Abstract][Full Text] [Related]
4. Early relapses, onset of progression, and late outcome in multiple sclerosis.
Scalfari A; Neuhaus A; Daumer M; Deluca GC; Muraro PA; Ebers GC
JAMA Neurol; 2013 Feb; 70(2):214-22. PubMed ID: 23407713
[TBL] [Abstract][Full Text] [Related]
5. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Scalfari A; Neuhaus A; Degenhardt A; Rice GP; Muraro PA; Daumer M; Ebers GC
Brain; 2010 Jul; 133(Pt 7):1914-29. PubMed ID: 20534650
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of the individual course of disease: the elements of time, heterogeneity and precision.
Daumer M; Neuhaus A; Herbert J; Ebers G
J Neurol Sci; 2009 Dec; 287 Suppl 1():S50-5. PubMed ID: 20106349
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.
Achiron A; Barak Y; Rotstein Z
Mult Scler; 2003 Oct; 9(5):486-91. PubMed ID: 14582775
[TBL] [Abstract][Full Text] [Related]
8. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Kerbrat A; Hamonic S; Leray E; Tron I; Edan G; Yaouanq J;
Eur J Neurol; 2015 Mar; 22(3):507-e35. PubMed ID: 25515927
[TBL] [Abstract][Full Text] [Related]
9. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J
JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998
[TBL] [Abstract][Full Text] [Related]
10. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
Shirani A; Zhao Y; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Gustafson P; Petkau J; Tremlett H
JAMA; 2012 Jul; 308(3):247-56. PubMed ID: 22797642
[TBL] [Abstract][Full Text] [Related]
11. Disability and prognosis of relapsing remitting multiple sclerosis, is it different in Iraqi patients?
Hasan ZN
Neurosciences (Riyadh); 2011 Jul; 16(3):233-6. PubMed ID: 21677613
[TBL] [Abstract][Full Text] [Related]
12. Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
Wybrecht D; Reuter F; Zaaraoui W; Faivre A; Crespy L; Rico A; Malikova I; Confort-Gouny S; Soulier E; Cozzone PJ; Pelletier J; Ranjeva JP; Audoin B
Mult Scler; 2012 Nov; 18(11):1585-91. PubMed ID: 22454097
[TBL] [Abstract][Full Text] [Related]
13. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.
Langer-Gould A; Popat RA; Huang SM; Cobb K; Fontoura P; Gould MK; Nelson LM
Arch Neurol; 2006 Dec; 63(12):1686-91. PubMed ID: 17172607
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Togha M; Karvigh SA; Nabavi M; Moghadam NB; Harirchian MH; Sahraian MA; Enzevaei A; Nourian A; Ghanaati H; Firouznia K; Jannati A; Shekiba M
Mult Scler; 2010 Jul; 16(7):848-54. PubMed ID: 20488825
[TBL] [Abstract][Full Text] [Related]
15. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
16. Predicting the course of relapsing-remitting MS using longitudinal disability curves.
Achiron A
J Neurol; 2004 Sep; 251 Suppl 5():v65-v68. PubMed ID: 15549358
[TBL] [Abstract][Full Text] [Related]
17. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.
Young PJ; Lederer C; Eder K; Daumer M; Neiss A; Polman C; Kappos L;
Neurology; 2006 Sep; 67(5):804-8. PubMed ID: 16966541
[TBL] [Abstract][Full Text] [Related]
18. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
19. What is the risk of permanent disability from a multiple sclerosis relapse?
Bejaoui K; Rolak LA
Neurology; 2010 Mar; 74(11):900-2. PubMed ID: 20231665
[TBL] [Abstract][Full Text] [Related]
20. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
